JP2610735B2 - 抗鬱剤および抗ストレス剤組成物 - Google Patents

抗鬱剤および抗ストレス剤組成物

Info

Publication number
JP2610735B2
JP2610735B2 JP3320532A JP32053291A JP2610735B2 JP 2610735 B2 JP2610735 B2 JP 2610735B2 JP 3320532 A JP3320532 A JP 3320532A JP 32053291 A JP32053291 A JP 32053291A JP 2610735 B2 JP2610735 B2 JP 2610735B2
Authority
JP
Japan
Prior art keywords
compound
formula
stress
compounds
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP3320532A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0525040A (ja
Inventor
− ウージェヌ・ケーヌ プテ
アルベルト・ビアンチェッティ
ジャック・シミアン
ティツィアノ・クロシ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of JPH0525040A publication Critical patent/JPH0525040A/ja
Application granted granted Critical
Publication of JP2610735B2 publication Critical patent/JP2610735B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP3320532A 1990-12-04 1991-12-04 抗鬱剤および抗ストレス剤組成物 Expired - Lifetime JP2610735B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9015171 1990-12-04
FR9015171A FR2669821A1 (fr) 1990-12-04 1990-12-04 Utilisation de phenylethanolaminotetralines pour la preparation de medicaments destines au traitement de la depression.

Publications (2)

Publication Number Publication Date
JPH0525040A JPH0525040A (ja) 1993-02-02
JP2610735B2 true JP2610735B2 (ja) 1997-05-14

Family

ID=9402882

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3320532A Expired - Lifetime JP2610735B2 (ja) 1990-12-04 1991-12-04 抗鬱剤および抗ストレス剤組成物

Country Status (13)

Country Link
US (1) US5270341A (https=)
EP (1) EP0489640B1 (https=)
JP (1) JP2610735B2 (https=)
AT (1) ATE143592T1 (https=)
AU (1) AU653968B2 (https=)
CA (1) CA2056906C (https=)
DE (1) DE69122480T2 (https=)
DK (1) DK0489640T3 (https=)
FR (1) FR2669821A1 (https=)
HU (1) HU207793B (https=)
IE (1) IE76322B1 (https=)
MX (1) MX9102365A (https=)
SG (1) SG47450A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2826651B1 (fr) * 2001-06-28 2005-09-02 Sanofi Synthelabo Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant
EP1623705A1 (en) * 2004-07-09 2006-02-08 Sanofi-Aventis Use of phenylethanolaminotetralines for preparing anxiolytic drugs
FR2890862B1 (fr) * 2005-09-19 2008-01-25 Sanofi Aventis Sa Association d'agoniste aux recepteurs beta 3 et d'inhibiteur de la recapture de monoamnies, compostion pharmaceutique la contenant et son utilisation en therapeutique.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH637363A5 (en) * 1977-11-24 1983-07-29 Sandoz Ag Process for preparing novel 2-aminotetralins
FR2584712B1 (fr) * 1985-07-10 1987-11-27 Midy Spa Phenylethanolamines a activite lipolytique, un procede pour leur preparation et compositions pharmaceutiques en contenant
IL79323A (en) * 1985-07-10 1990-03-19 Sanofi Sa Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them
US4927955A (en) * 1987-08-12 1990-05-22 Sanofi Process for the O-alkylation of N-(hydroxy)aralkylphenylethanolamines
DE3872100T2 (de) * 1987-08-12 1993-01-28 Sanofi Elf Verfahren zur herstellung von phenylaethanolaminotetralinen.
EP0452390B1 (en) * 1989-01-09 1994-10-26 The Upjohn Company Halo substituted aminotetralins
FR2643076B1 (fr) * 1989-02-14 1991-06-21 Midy Spa Carboxyalkyl-ethers de la 2-amino-7-hydroxytetraline
DE69028877T2 (de) * 1989-06-13 1997-02-27 Sanofi Sa Verwendung von Phenylethanolaminen zur Herstellung von Medikamenten gegen Augenleiden

Also Published As

Publication number Publication date
EP0489640B1 (fr) 1996-10-02
DE69122480T2 (de) 1997-04-24
JPH0525040A (ja) 1993-02-02
HUT59595A (en) 1992-06-29
SG47450A1 (en) 1998-04-17
US5270341A (en) 1993-12-14
CA2056906A1 (en) 1992-06-05
DK0489640T3 (da) 1997-02-17
FR2669821B1 (https=) 1994-12-09
IE914195A1 (en) 1992-06-17
AU653968B2 (en) 1994-10-20
HU207793B (en) 1993-06-28
IE76322B1 (en) 1997-10-22
DE69122480D1 (de) 1996-11-07
EP0489640A1 (fr) 1992-06-10
FR2669821A1 (fr) 1992-06-05
AU8839591A (en) 1992-06-11
CA2056906C (en) 1998-04-28
HU913800D0 (en) 1992-02-28
ATE143592T1 (de) 1996-10-15
MX9102365A (es) 1992-09-01

Similar Documents

Publication Publication Date Title
US5990159A (en) Use of 5HT4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors
HUT76852A (en) Use of benzotiophene derivatives for production of pharmaceutical compositions useful for inhibiting conditions associated with neuro-peptide y
EP0687472A2 (en) Potentiation of drug response by a serotonin 1A receptor antagonist
EP0714663A2 (en) Potentiation of drug response by a serotonin 1A receptor antagonist
JPH0393718A (ja) 早発射精治療剤
JP2009536176A (ja) 閉経後の性的欲求障害の治療のためのフリバンセリンの使用
US4590213A (en) Anti-anxiety method
US20050215617A1 (en) Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
US20040019101A1 (en) Methods of treating gastrointestinary and genitourinary pain disorders
EP1154795A1 (en) Method of treating and diagnosing restless legs syndrome and corresponding means
JPH05509293A (ja) 不整脈および発作の治療における５―ｈｔ４受容体拮抗剤の使用
JP2610735B2 (ja) 抗鬱剤および抗ストレス剤組成物
WO1996022085A1 (en) The use of sertraline to treat cancer patients
EP0412901B1 (fr) Utilisation de trifluorométhyl-phényltétrahydropyridines pour la préparation de médicaments destinés à combattre les troubles de la motricité intestinale
HU214588B (hu) Eljárás bicikloheptán-származékot tartalmazó, CCK-rendszer gátló hatású gyógyászati készítmények előállítására
HUP0200655A2 (hu) Osanetant alkalmazása kedélyállapot-rendellenességek kezelésére használható gyógyszerek előállítására
AU643487B2 (en) Use of optically pure s(-) atenolol for the treatment of cardiovascular disorders
JPH0393719A (ja) セルトラリンからなる薬物依存症治療剤
EP1928448B1 (fr) ASSOCIATION D'AGONISTE AUX RECEPTEURS ß3 ET D'INHIBITEURS DE LA RECAPTURE DE MONOAMINES, COMPOSITION PHARMACEUTIQUE LA CONTENANT ET SON UTILISATION EN THERAPEUTIQUE
US20080176951A1 (en) Methods of treating gastrointestinary and genitourinary pain disorders
WO2018069770A1 (en) Methods of treatment using eluxadoline
HK1013797A (en) Potentiation of drug response by a serotonin 1a receptor antagonist
HK1013798A (en) Potentiation of drug response by a serotonin 1a receptor antagonist
HK1093890A (en) Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
HK1035143B (en) Pharmaceutical combinations containing tramadol for the production of a medicament for the treatment of migraine or migrainoid headaches

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 19961217

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R370 Written measure of declining of transfer procedure

Free format text: JAPANESE INTERMEDIATE CODE: R370

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080213

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090213

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100213

Year of fee payment: 13

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100213

Year of fee payment: 13

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110213

Year of fee payment: 14

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120213

Year of fee payment: 15

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120213

Year of fee payment: 15